Top pharmaceuticals in 2014 by ad dollars spent

Invokana, which treats type 2 Diabetes, is once again the top drug product advertised in medical journals by dollars in 2014. For the second year in a row, this product from Janssen Pharmaceuticals comprises about 3% of the total share among all drugs. Antidepressant Brintellix (manufactured by Takeda Pharmaceuticals) stormed onto the pharmaceutical advertising scene, achieving a nearly 2% share in 2014.

Top 5 Print Ad Drugs (Dollars): January–December 2014
  1. Invokana – $16.45 MM (+3%)
  2. Brintellix Tablets – $10.97 MM (+16,908%)
  3. Xarelto Tablets – $6.53 MM (-51%)
  4. Latuda – $5.99 MM (+14%)
  5. Belviq – $5.58 MM (+70%)

Percentage changes shown compare January–December 2014 to that same time period in 2013. For more information on these or other healthcare advertising insights, let us know.

Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in the professional healthcare arena.



Search article